18A新贵,暴涨78%

新康界
Jun 29, 2025

6月23日,又一家Biotech成功在港交所敲响钟声。药捷安康发行价为13.15港元/股,盘中最高涨超80%,最终以78.71%的涨幅完成收盘,总市值93.27亿港元。2025年港股生物科技IPO热潮中,药捷安康的登场宛如一场悲壮突围——这是61岁海归博士吴永谦第四次递表港交所。公司手握全球首创胆管癌药物Tinengotinib,却背负两年半亏损7.5亿,核心授权合作终止,现金流仅能撑12个月的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10